Aspergillus fumigatus extract differentially regulates antigen-specific CD4+ and CD8+ T cell responses to promote host immunity

Journal of Leukocyte Biology

Volumn 80, Issue 3, 2006, Pages 529-537

  Tao, Jianming ^a   Segal, Brahm H ^a   Eppolito, Cheryl ^a   Li, Qingsheng ^a   Dennis, Carly G ^a   Youn, Richard ^a   Shrikant, Protul A ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Cell activation; Cell differentiation; Cytotoxicity; Lymph nodes; Rodent; Spleen; Transgenic; Tumor immunity

Indexed keywords

GAMMA INTERFERON; OVALBUMIN; PROBIOTIC AGENT; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; HOST RESISTANCE; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADJUVANTS, IMMUNOLOGIC; ADOPTIVE TRANSFER; ANIMALS; ASPERGILLUS FUMIGATUS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; CHICKENS; IMMUNITY, CELLULAR; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OVALBUMIN;

ASPERGILLUS; ASPERGILLUS FUMIGATUS; RODENTIA;

EID: 33751530691     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0106026     Document Type: Article

References (37)

1. McNeil, M. M., Nash, S. L., Hajjeh, R. A., Phelan, M. A., Conn, L. A., Plikaytis, B. D., Warnock, D. W. (2001) Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin. Infect. Dis. 33, 641-647.
2. Patterson, T. F., Kirkpatrick, W. R., White, M., Hiemenz, J. W., Wingard, J. R., Dupont, B., Rinaldi, M. G., Stevens, D. A., Graybill, J. R. (2000) Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine (Baltimore) 79, 250-260.
3. Baddley, J. W., Stroud, T. P., Salzman, D., Pappas, P. G. (2001) Invasive mold infections in allogeneic bone marrow transplant recipients. Clin. Infect. Dis. 32, 1319-1324.
4. Marr, K. A., Carter, R. A., Boeckh, M., Martin, P., Corey, L. (2002) Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 100, 4358-4366.
5. Stevens, D. A., Moss, R. B., Kurup, V. P., Knutsen, A. P., Greenberger, P., Judson, M. A., Denning, D. W., Crameri, R., Brody, A. S., Light, M., Skov, M., Maish, W., Mastella, G. (2003) Allergic bronchopulmonary aspergillosis in cystic fibrosis - state of the art: Cystic Fibrosis Foundation Consensus Conference. Clin. Infect. Dis. 37 (Suppl. 3), S225-S264.
6. Kurup, V. P., Grunig, G. (2002) Animal models of allergic bronchopulmonary aspergillosis. Mycopathologia 153, 165-177.
7. Svirshchevskaya, E. V., Kurup, V. P. (2003) Immunotherapy of allergic bronchopulmonary aspergillosis: a clinical and experimental approach. Front. Biosci. 8, s92-s101.
8. Banerjee, B., Kelly, K. J., Fink, J. N., Henderson Jr., J. D., Bansal, N. K., Kurup, V. P. (2004) Modulation of airway inflammation by immunostimulatory CpG oligodeoxynucleotides in a murine model of allergic aspergillosis. Infect. Immun. 72, 6087-6094.
9. Cenci, E., Mencacci, A., Bacci, A., Bistoni, F., Kurup, V. P., Romani, L. (2000) T cell vaccination in mice with invasive pulmonary aspergillosis. J. Immunol. 165, 381-388.
10. Ito, J. I., Lyons, J. M. (2002) Vaccination of corticosteroid immunosuppressed mice against invasive pulmonary aspergillosis. J. Infect. Dis. 186, 869-871.
11. Hogaboam, C. M., Takahashi, K., Ezekowitz, R. A., Kunkel, S. L., Schuh, J. M. (2004) Mannose-binding lectin deficiency alters the development of fungal asthma: effects on airway response, inflammation, and cytokine profile. J. Leukoc. Biol. 75, 805-814.
12. Hogaboam, C. M., Blease, K., Schuh, J. M. (2003) Cytokines and chemokines in allergic bronchopulmonary aspergillosis (ABPA) and experimental Aspergillus-induced allergic airway or asthmatic disease. Front. Biosci. 8, e147-e156.
13. Romani, L. (2004) Immunity to fungal infections. Nat. Rev. Immunol. 4, 1-23.
14. Netea, M. G., Warris, A., Van der Meer, J. W., Fenton, M. J., Verver-Janssen, T. J., Jacobs, L. E., Andresen, T., Verweij, P. E., Kullberg, B. J. (2003) Aspergillus fumigatus evades immune recognition during germination through loss of Toll-like receptor-4-mediated signal transduction. J. Infect. Dis. 188, 320-326.
15. Mullbacher, A., Eichner, R. D. (1984) Immunosuppression in vitro by a metabolite of a human pathogenic fungus. Proc. Natl. Acad. Sci. USA 81, 3835-3837.
16. Tsunawaki, S., Yoshida, L. S., Nishida, S., Kobayashi, T., Shimoyama, T. (2004) Fungal metabolite gliotoxin inhibits assembly of the human respiratory burst NADPH oxidase. Infect. Immun. 72, 3373-3382.
17. Stanzani, M., Orciuolo, E., Lewis, R., Kontoyiannis, D. P., Martins, S. L., St John, L. S., Komanduri, K. V. (2005) Aspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes. Blood 105, 2258-2265.
18. Banerjee, B., Greenberger, P. A., Fink, J. N., Kurup, V. P. (1999) Conformational and linear B-cell epitopes of Asp f 2, a major allergen of Aspergillus fumigatus, bind differently to immunoglobulin E antibody in the sera of allergic bronchopulmonary aspergillosis patients. Infect. Immun. 67, 2284-2291.
19. Svirshchevskaya, E. V., Alekseeva, L., Marchenko, A., Viskova, N., Andronova, T. M., Benevolenskii, S. V., Kurup, V. P. (2002) Immune response modulation by recombinant peptides expressed in virus-like particles. Clin. Exp. Immunol. 127, 199-205.
20. Hogquist, K. A., Jameson, S. C., Heath, W. R., Howard, J. L., Bevan, M. J., Carbone, F. R. (1994) T cell receptor antagonist peptides induce positive selection. Cell 76, 17-27.
21. Barnden, M. J., Allison, J., Heath, W. R., Carbone, F. R. (1998) Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76, 34-40.
22. Shrikant, P., Khoruts, A., Mescher, M. F. (1999) CTLA-4 blockade reverses CD8+ T cell tolerance to tumor by a CD4+ T cell- and IL-2-dependent mechanism. Immunity 11, 483-493.
23. Shrikant, P., Mescher, M. F. (2002) Opposing effects of IL-2 in tumor immunotherapy: promoting CD8 T cell growth and inducing apoptosis. J. Immunol. 169, 1753-1759.
24. Goldberg, J., Shrikant, P., Mescher, M. F. (2003) In vivo augmentation of tumor-specific CTL responses by class I/peptide antigen complexes on microspheres (large multivalent immunogen). J. Immunol. 170, 228-235.
25. Mueller, S. N., Jones, C. M., Smith, C. M., Heath, W. R., Carbone, F. R. (2002) Rapid cytotoxic T lymphocyte activation occurs in the draining lymph nodes after cutaneous herpes simplex virus infection as a result of early antigen presentation and not the presence of virus. J. Exp. Med. 195, 651-656.
26. Abele, R., Tampe, R. (2006) Modulation of the antigen transport machinery TAP by friends and enemies. FEBS Lett. 580, 1156-1163.
27. Ramadan, G., Davies, B., Kurup, V. P., Keever-Taylor, C. A. (2005) Generation of cytotoxic T cell responses directed to human leucocyte antigen Class I restricted epitopes from the Aspergillus f16 allergen. Clin. Exp. Immunol. 140, 81-91.
28. Yamashita, Y., Okano, M., Yoshino, T., Hattori, H., Yamamoto, T., Watanabe, T., Takishita, T., Akagi, T., Nishizaki, K. (2002) Carbohydrates expressed on Aspergillus fumigatus induce in vivo allergic Th2-type response. Clin. Exp. Allergy 32, 776-782.
29. Lemaitre, B., Nicolas, E., Michaut, L., Reichhart, J. M., Hoffmann, J. A. (1996) The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86, 973-983.
30. Netea, M. G., Van Der Graaf, C. A., Vonk, A. G., Verschueren, I., Van Der Meer, J. W., Kullberg, B. J. (2002) The role of Toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. J. Infect. Dis. 185, 1483-1489.
31. Shoham, S., Huang, C., Chen, J. M., Golenbock, D. T., Levitz, S. M. (2001) Toll-like receptor 4 mediates intracellular signaling without TNF-α release in response to Cryptococcus neoformans polysaccharide capsule. J. Immunol. 166, 4620-4626.
32. Wang, J. E., Warris, A., Ellingsen, E. A., Jorgensen, P. F., Flo, T. H., Espevik, T., Solberg, R., Verweij, P. E., Aasen, A. O. (2001) Involvement of CD14 and Toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae. Infect. Immun. 69, 2402-2406.
33. Janssen, E. M., Lemmens, E. E., Wolfe, T., Christen, U., von Herrath, M. G., Schoenberger, S. P. (2003) CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 421, 852-856.
34. Schoenberger, S. P., Toes, R. E., van der Voort, E. I., Offringa, R., Melief, C. J. (1998) T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393, 480-483.
35. Huffnagle, G. B., Yates, J. L., Lipscomb, M. F. (1991) Immunity to a pulmonary Cryptococcus neoformans infection requires both CD4+ and CD8+ T cells. J. Exp. Med. 173, 793-800.
36. Buller, R. M., Holmes, K. L., Hugin, A., Frederickson, T. N., Morse III, H. C. (1987) Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells. Nature 328, 77-79.
37. Wuthrich, M., Filutowicz, H. I., Warner, T., Deepe Jr., G. S., Klein, B. S. (2003) Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells: implications for vaccine development in immune-deficient hosts. J. Exp. Med. 197, 1405-1416.